Kathleen and Laurie have worked at Fortune 500 companies such as Abbott Laboratories, Baxter Healthcare, Cardinal Health, Hospira, and S. C. Johnson & Sons. A significant achievement includes the build-out of microbiological infrastructure which allowed for in-house testing of bioburden and endotoxin. This project was completed in five months with an annual cost savings of $500,000 and a fourteen-day reduction in cycle-time of product-release to market.
April, 2024
Friday
August 26,2019
We have received your appointment and will send you a confirmation to your provided email upon approval.